Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Tumor |
| Start Date: | September 1, 2005 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00413322 |
| Study Type: | Interventional |
| Intervention: | Drug: belinostat|Drug: 5-Fluorouracil (5-FU) |
| Study Design: | Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | TopoTarget A/S |
| Ages: | Adult|Senior |
| Enrollment: | 35 |
| Funded By: | Industry |
| First Received: | December 18, 2006 |
| End Date: | June 1, 2008 |
| Last Updated: | March 31, 2009 |
| Last Verified: | March 1, 2009 |